Evidence map›Paper›PMID 42254014›Full record

ArticleFrontiers in immunology2026

Guillain-Barré syndrome following

Anping Liu, Yuling Liu, Lili Shi, Binyuan Xiong, Dan Zhi, Haizhen Duan, Anyong Yu

Abstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anping LiuDepartment of Emergency Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Yuling LiuZunyi Medical University College of Science and Technology, , Zunyi, China.
Lili ShiZunyi Medical University, Zunyi, China.
Binyuan XiongDepartment of Emergency Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Dan ZhiDepartment of Emergency Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Haizhen DuanDepartment of Emergency Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Anyong YuDepartment of Emergency Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Guillain-Barré syndrome (GBS) is an acute immune-mediated polyneuropathy, whereas Escherichia coli meningitis following cupping and acupuncture is a rare but severe infection. GBS as a neurological complication after E. coli meningitis is exceedingly uncommon. We report the case of a 53-year-old woman with systemic lupus erythematosus and chronic renal failure who developed headache, vomiting, and altered consciousness four days after undergoing cupping and acupuncture for low back pain. Cerebrospinal fluid (CSF) analysis and next-generation sequencing confirmed E. coli meningitis. Although meningeal signs improved with targeted antibiotic therapy, she subsequently developed progressive flaccid quadriparesis, ophthalmoparesis, and areflexia. Further evaluation revealed CSF albuminocytologic dissociation, positive serum anti-GM1 and anti-GT1a IgG antibodies, and electromyographic findings consistent with acute demyelinating polyneuropathy, leading to a diagnosis of GBS. The patient's neurological symptoms improved significantly following intravenous immunoglobulin therapy. This case illustrates that E. coli meningitis, potentially introduced via cupping or acupuncture, can trigger GBS as a severe neurological sequela. It also underscores the importance of considering GBS in the differential diagnosis when patients with bacterial meningitis develop progressive, unexplained flaccid paralysis during or after treatment. Early recognition, timely immunomodulation, and sustained rehabilitation are crucial for reducing disability.

Indexed as

Guillain-Barre SyndromeMeningitis, Escherichia coliEscherichia coliFemaleHumansImmunoglobulins, IntravenousMiddle AgedImmunoglobulins, Intravenousacupuncturebacterial meningitiscase reportcupping therapyEscherichia coliGuillain-Barré syndromesystemic lupus erythematosus

Identifiers

PMID42254014
PMCPMC13236915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.